Fig. 2From: NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthmaOverview of ongoing phase 2 and phase 3 clinical studies of tezepelumab. ACQ, Asthma Control Questionnaire; BD, bronchodilator; EOS, blood eosinophils; FEV1, forced expiratory volume in 1 s; HRQoL, health-related quality of life; ICS, inhaled corticosteroids; LTE, long-term extension; N, number of patients; OCS, oral corticosteroids; Q4W, every 4 weeks; RBM, reticular basement membrane; SC, subcutaneously; T2, type 2Back to article page